Drug Approval | August 07, 2025
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
This is the group’s first NoC approval in Canada
This is the group’s first NoC approval in Canada
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Cenexi reports an EBITDA breakeven for the quarter
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Vasograin Plus represents a major advancement in the treatment of migraine
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Subscribe To Our Newsletter & Stay Updated
